MYD88 mutations can be used to identify malignant pleural effusions in Waldenström macroglobulinaemia

Br J Haematol. 2018 Feb;180(4):578-581. doi: 10.1111/bjh.14386. Epub 2016 Oct 17.

Authors

Joshua N Gustine¹, Kirsten Meid¹, Zachary R Hunter¹, Lian Xu¹, Steven P Treon^{1

2}, Jorge J Castillo^{1

2}

Affiliations

¹ Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.
² Department of Medicine, Harvard Medical School, Boston, MA, USA.

PMID: 27748515
DOI: 10.1111/bjh.14386

No abstract available

Keywords: MYD88; Waldenström macroglobulinaemia; pleural effusion.

Publication types

Letter

MeSH terms

Genetic Predisposition to Disease
Humans
Mutation*
Myeloid Differentiation Factor 88 / genetics*
Pleural Effusion, Malignant / diagnosis*
Pleural Effusion, Malignant / etiology*
Pleural Effusion, Malignant / therapy
Prognosis
Waldenstrom Macroglobulinemia / complications*
Waldenstrom Macroglobulinemia / genetics*
Waldenstrom Macroglobulinemia / therapy

Substances

Myeloid Differentiation Factor 88